PHYLLIS GARDNER
CIK 1238646 · last filed 2023-06-15
PHYLLIS GARDNER is a corporate insider who has filed 22 SEC Form 4 insider transactions across 4 companies since 2014. The most recent filing, for MDXG, was dated Oct 10, 2024. Across all open-market trades the lifetime net is −$168.0K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $498.5K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$498.5K
4
22
-$168.0K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MDXG | Director | 117,024 | $4.26 | $498.5K | $0 | 4 | 2023-06-15 |
| CohBar, Inc. (CWBR) Delisted | Director | — | $0.41 | — | $0 | 2 | 2021-04-28 |
| Revance Therapeutics, Inc. (RVNC) Delisted | Director | 460,746 | $3.65 | $1.68M | -$168.0K | 8 | 2020-05-15 |
| Corium International, Inc. (CORI) Delisted | Director | 0 | — | — | $0 | 7 | 2018-11-28 |
Recent Filings
22 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-10-10 | MDXG | Notice (144) | −30,000 | -$165.6K | EDGAR |
| 2023-06-15 | MDXG | Grant (A) | +35,354 | $175.0K | EDGAR |
| 2022-06-13 | MDXG | Grant (A) | +44,191 | $175.0K | EDGAR |
| 2021-05-28 | MDXG | Grant (A) | +17,056 | $175.0K | EDGAR |
| 2021-04-29 | MDXG | Grant (A) | +20,423 | $218.7K | EDGAR |
| 2021-04-28 | CohBar, Inc. (CWBR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-05-15 | Revance Therapeutics, Inc. (RVNC) Delisted | Grant (A) | +6,000 | $0 | EDGAR |
| 2019-05-10 | Revance Therapeutics, Inc. (RVNC) Delisted | Grant (A) | +4,500 | $0 | EDGAR |
| 2019-02-12 | CohBar, Inc. (CWBR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-11-28 | Corium International, Inc. (CORI) Delisted | Disp (D) | −34,203 | -$427.5K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.